Additional studies on digestive system cancers found that CEACAM6 could promote invasion and metastasis through epithelial-to-mesenchymal transition (EMT) by activating the PI3K/AKT signalling pathway [40]. This evidence concerns the gene CEACAM6 and digestive system cancer.